Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster... Show more
LAB is expected to report earnings to fall 90.14% to 0 cents per share on November 10
Q3'26
Est.
$-0.01
Q2'26
Missed
by $0.06
Q1'26
Beat
by $0.37
Q4'25
Beat
by $0.10
Q3'25
Missed
by $0.04
The last earnings report on August 05 showed earnings per share of -7 cents, missing the estimate of -1 cents. With 2.01M shares outstanding, the current market capitalization sits at 262.64M.